Literature DB >> 10903330

Cellular mechanisms of insulin resistance.

G I Shulman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10903330      PMCID： PMC314317          DOI： 10.1172/JCI10583

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  43 in total

1.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

Review 3.  Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes.

Authors:  B B Kahn
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 4.  Glucose toxicity.

Authors:  L Rossetti; A Giaccari; R A DeFronzo
Journal:  Diabetes Care       Date:  1990-06       Impact factor: 19.112

5.  Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans.

Authors:  S M Haffner; M P Stern; J Dunn; M Mobley; J Blackwell; R N Bergman
Journal:  Metabolism       Date:  1990-08       Impact factor: 8.694

6.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

Authors:  J H Warram; B C Martin; A S Krolewski; J S Soeldner; C R Kahn
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

7.  Mechanisms of fatty acid-induced inhibition of glucose uptake.

Authors:  G Boden; X Chen; J Ruiz; J V White; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Damsbo; A Vaag; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

9.  A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

Authors:  N D Oakes; C J Kennedy; A B Jenkins; D R Laybutt; D J Chisholm; E W Kraegen
Journal:  Diabetes       Date:  1994-10       Impact factor: 9.461

10.  Reduced expression of hexokinase II in insulin-resistant diabetes.

Authors:  S S Braithwaite; B Palazuk; J R Colca; C W Edwards; C Hofmann
Journal:  Diabetes       Date:  1995-01       Impact factor: 9.461
View more
  699 in total

Review 1.  Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.

Authors:  M K Cavaghan; D A Ehrmann; K S Polonsky
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Signaling pathways in insulin action: molecular targets of insulin resistance.

Authors:  J E Pessin; A R Saltiel
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  The effect of salicylates on insulin sensitivity.

Authors:  M G Netea; C J Tack; P M Netten; J A Lutterman; J W Van der Meer
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  Turning down insulin signaling.

Authors:  M J Birnbaum
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

5.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice.

Authors:  Tahar Hajri; Xiao Xia Han; Arend Bonen; Nada A Abumrad
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 6.  Apelin and insulin resistance: another arrow for the quiver?

Authors:  Shiming Xu; Philip S Tsao; Patrick Yue
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

Review 7.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

8.  Intramyocellular lipids: maker vs. marker of insulin resistance.

Authors:  Zengkui Guo
Journal:  Med Hypotheses       Date:  2007-09-04       Impact factor: 1.538

9.  GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.

Authors:  Ko Kotani; Odile D Peroni; Yasuhiko Minokoshi; Olivier Boss; Barbara B Kahn
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 10.  Lipid-induced insulin resistance in the liver: role of exercise.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2004       Impact factor: 11.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.